Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health, through the National Heart, Lung, and Blood Institute, is seeking contractor support for the Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD) project. The primary objective is to build and maintain a cohort of individuals with sickle cell disease who have undergone either gene therapy or hematopoietic cell transplantation. The contractor will be responsible for sustaining long-term follow-up activities for enrolled participants to help determine the safety, durability, and effectiveness of these treatments. This initiative aims to provide rigorous comparisons between patients receiving these transformative therapies and untreated individuals with sickle cell disease. The project is categorized under NAICS code 541715 and is managed by the National Institutes of Health, with program coordination handled by Lisbeth Welniak and contracting oversight provided by Elizabeth Bulger.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from National Institutes of Health → National Institutes Of Health
Same awarding agency
